A healthy cardiovascular system is essential to good health. That’s why at Abbott, we’re advancing the treatment of heart and vascular disease through breakthrough medical technologies that are less invasive, allowing people to restore their health and get on with their lives.
Abbott focuses on improving treatment options for people with coronary artery disease, mitral regurgitation and peripheral artery disease. We’re working on timely advances and innovative technologies that have the potential to improve the way doctors treat people with vascular diseases.
Abbott’s vascular manufacturing facility in Clonmel helps meet worldwide demand for vascular devices.
The original 150,000-square-foot facility was established on 55 acres by Digital Corp in 1980. Today, the modern 250,000-square-foot facility on a 19-acre site is a centre of excellence in the manufacturing of vascular devices.
Abbott’s vascular business in Clonmel manufactures a broad range of vascular devices, including stent delivery systems.
Key products include:
Abbott Vascular, Clonmel
Tel: +353 (0)52 617 3000
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.